M.-F. Leconte des Floris
University of Franche-Comté
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M.-F. Leconte des Floris.
Transfusion Clinique Et Biologique | 2010
I. Hervé; M. Simonet; Danielle Rebibo; M.-F. Leconte des Floris; M. Taouqi-Le Cann; S. Jbilou; A. Brunet
Post donation information management is a fundamental axis of haemovigilance in terms of blood safety. It requires an organization ensuring a permanent reactivity, a good sensitization of French National Blood Service professionals and needs also a strong awareness of blood donors. Previous identification of stakeholders to warn during these kinds of alerts is essential to avoid the use of any blood product presenting a potential risk. The recent implementation of a consensual internal document aims to target the reinforcement of a homogeneous decision-making process, combining blood product self-sufficiency and above all recipient safety.
Transfusion Clinique Et Biologique | 2002
J.F Jusot; C Aubert; M.-F. Leconte des Floris; Michel Rotily; F Lançon; C Colin; A.M Jullien; J.J Fournel; L Laubriat; G Fabre; C Botté; P Montcharmont
AIMS OF THE STUDY In spite of official recommendations and measures in France, screening strategies of hepatitis C performed in the field of transfusion are not clearly known. The aim of this study is to describe the screening strategies before and after the current year of the transfusion in blood recipients in several French medical departments and hospitals. MATERIALS AND METHODS A qualitative study using the key informant technique was carried out. A sample of 179 departments and 64 hospitals in charge of patients transfused with low or high-volumes of homologous blood products was constituted. The key informants were asked about the number of homologous blood products, the number of recipients transfused in the hospital, the volume of transfusion performed, the existence of a single defined screening strategy, the time of prescription of the biological tests (before or after transfusion), the tests performed on cryopreserved blood samples, and the indications of the transfusion. RESULTS The main screening strategy was HCV serology (second or third generation of enzyme immunoassays) with transaminase assessments before and after transfusion in 14% of the declared screening strategies. Screening tests were more frequently prescribed after transfusion, in at least 64% of the declared screening strategies according to the volume of transfusion. HCV serology was the common test prescribed in 61 and 50% of the screening strategies for low and high-volume transfusion respectively. The screening strategies showed a large heterogeneity combining HCV serology, transaminase assessment, before or after transfusion. CONCLUSION A great heterogeneity of screening strategies was found. The most frequent was HCV serology with transaminase assessment before and after transfusion. Recommendations on screening strategies are needed in order to limit practice heterogeneity. This study will help building a cost-efficacy model in order to guide public health decision making.
Transfusion Clinique Et Biologique | 2009
J.-F. Quaranta; F. Berthier; R. Courbil; F. Courtois; F. Chenais; C. Waller; M.-F. Leconte des Floris; Georges Andreu; O. Fontaine; C. Le Niger; M. Puntous; A. Mercadier; L. Nguyen; Elisabeth Pélissier; G. Gondrexon; P. Staccini
Transfusion Clinique Et Biologique | 2000
P. Morel; M.-F. Leconte des Floris; L. Bardiaux; Fabienne Pouthier; Patrick Herve
Transfusion Clinique Et Biologique | 2013
P. Morel; Marie Deschaseaux; Xavier Bertrand; C. Naegelen; M.-F. Leconte des Floris; L. Bardiaux
Transfusion Clinique Et Biologique | 2005
P. Morel; Marie Deschaseaux; C. Naegelen; L. Bardiaux; M.-F. Leconte des Floris; Fabienne Pouthier
Transfusion Clinique Et Biologique | 2012
A. Bazin; C. Trophilme; J.Y. Py; Cyril Caldani; G. Daurat; L. Hauser; M.-F. Leconte des Floris; P. Moncharmont; Josiane Pillonel; P. Renaudier; X. Richomme; A. Sailliol; K. Boudjedir; N. Ounnoughene; I. Sandid; M.P. Vo-Mai; M. Carlier
Transfusion Clinique Et Biologique | 1995
I. Baldi; S. Lawson-Ayayi; P. Perez; G. Chêne; M.-F. Leconte des Floris; M. Vicariot; M. Vignal; G. Palmer; L.R. Salmi
Transfusion Clinique Et Biologique | 2012
L. Bardiaux; E. Boulanger; M.-F. Leconte des Floris; V. Bourcier; D. Cottier
Transfusion Clinique Et Biologique | 2014
M.-F. Leconte des Floris; Josiane Pillonel; S. Laperche; L. Hauser; C. Lefort; J.Y. Py; I. Hervé; R. Djoudi
Collaboration
Dive into the M.-F. Leconte des Floris's collaboration.
Agence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputsAgence française de sécurité sanitaire des produits de santé
View shared research outputs